Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Malnutrition 1 Hyperphagia 1 Hematopoietic and Lymphatic System Neoplasm 1 Esophageal Neoplasms 1

Interventions

Oxaliplatin 66 pembrolizumab 47 Fluorouracil 44 Capecitabine 39 Nivolumab 33 Leucovorin 32 Paclitaxel 28 Trastuzumab 20 Docetaxel 19 Cisplatin 18 S 1 (combination) 17 Bevacizumab 15 Irinotecan 14 Drug Therapy 14 tislelizumab 12 Ramucirumab 12 Cyclophosphamide 12 fludarabine 10 Carboplatin 10 sintilimab 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 trastuzumab deruxtecan 8 atezolizumab 8 Specimen Handling 8 Biopsy 8 durvalumab 7 Surgical Procedures, Operative 7 Gemcitabine 7 zolbetuximab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × Parenteral Nutrition × 1 year × Clear all

NCT07604857 2026-05-22

BRIDGE-GC

The Catholic University of Korea

Phase NA Completed

Gastrointestinal

Hyperphagia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡